慢性疲劳综合征 中国就医指南

{ "intro_en": "Chronic Fatigue Syndrome (CFS), also known as Myalgic Encephalomyelitis (ME/CFS), is a complex, debilitating, multisystem neuroimmune disorder characterized by profound, unexplained fatigue that persists for at least six months, is not alleviated by rest, and is accompanied by post-exertional malaise (PEM)—a hallmark symptom where physical or cognitive exertion triggers a worsening of symptoms lasting more than 24 hours. Other core features include unrefreshing sleep, cognitive impairment ('brain fog'), orthostatic intolerance, and widespread pain. While historically mischaracterized as a psychiatric condition, contemporary research—particularly within rheumatology and immunology—confirms ME/CFS as a biologically grounded illness involving dysregulation of the immune system, autonomic nervous system, mitochondrial energy metabolism, and neuroinflammation. Pathogenesis remains incompletely understood but involves aberrant cytokine profiles (e.g., elevated IL-1β, TNF-α), chronic low-grade inflammation, impaired natural killer (NK) cell function, HPA axis dysfunction, and potential viral reactivation (e.g., EBV, HHV-6). Epidemiologic studies estimate a global prevalence of 0.2–0.4%, translating to approximately 1–2 million affected individuals in China alone. Women are affected 2–4 times more frequently than men, with peak onset between ages 30–50. Risk factors include prior infectious triggers (e.g., infectious mononucleosis, SARS-CoV-2), genetic predisposition (e.g., HLA and cytokine gene polymorphisms), autoimmune comorbidity (e.g., Sjögren’s syndrome, lupus), early-life stress, and environmental exposures. Importantly, ME/CFS frequently co-occurs with other rheumatic and immune-mediated conditions—including fibromyalgia, autoimmune thyroiditis, and mast cell activation syndrome—underscoring its relevance to Rheumatology and Immunology departments. The disease imposes severe functional impairment: over 75% of patients report substantial limitations in daily activities; 25% are homebound or bedbound; and employment rates drop by more than 50%. Quality of life metrics consistently rank ME/CFS lower than those for multiple sclerosis, heart failure, and end-stage renal disease. Patients experience high rates of stigma, diagnostic delay (average 4–7 years), and inadequate access to specialized care—factors that compound psychological distress, social isolation, and economic hardship. Early recognition by rheumatologists—especially when fatigue overlaps with arthralgia, myalgia, sicca symptoms, or autoantibody positivity—is critical for differential diagnosis and integrated management.", "treatment_cost_en": "1200-4500 USD", "treatment_duration_en": "3-6 months", "recommended_hospitals_en": ["Peking Union Medical College Hospital", "Ruijin Hospital, Shanghai Jiao Tong University School of Medicine", "West China Hospital, Sichuan University", "Zhongshan Hospital Fudan University"], "seo_keywords_en": ["Chronic Fatigue Syndrome", "Chronic Fatigue Syndrome treatment cost", "Chronic Fatigue Syndrome treatment duration", "Chronic Fatigue Syndrome how to treat", "Chronic Fatigue Syndrome symptoms", "Chronic Fatigue Syndrome best hospital", "Chronic Fatigue Syndrome China treatment", "ME/CFS diagnosis", "ME/CFS rheumatology", "chronic fatigue syndrome immune dysfunction", "post-exertional malaise treatment", "CFS and autoimmune disease", "myalgic encephalomyelitis specialist China", "CFS fatigue management", "rheumatologist for chronic fatigue"], "tags": [ {"en":"Chronic Fatigue Syndrome","zh":"慢性疲劳综合征","ru":"Хронический синдром усталости","ar":"متلازمة التعب المزمن","es":"Síndrome de fatiga crónica","fr":"Syndrome de fatigue chronique","pt":"Síndrome da fadiga crônica"}, {"en":"Myalgic Encephalomyelitis","zh":"肌痛性脑脊髓炎","ru":"Миалгическая энцефаломиелит","ar":"التهاب الدماغ والنخاع العضلي","es":"Encefalomielitis miálgica","fr":"Encéphalomyélite myalgique","pt":"Encefalomielite miálgica"}, {"en":"Post-Exertional Malaise","zh":"运动后不适","ru":"Ухудшение состояния после нагрузки","ar":"التوعك بعد الجهد","es":"Malestar pos-esfuerzo","fr":"Malaise post-effort","pt":"Mal-estar pós-esforço"}, {"en":"Rheumatology and Immunology","zh":"风湿免疫科","ru":"Ревматология и иммунология","ar":"الروماتولوجيا والمناعة","es":"Reumatología e inmunología","fr":"Rhumatologie et immunologie","pt":"Reumatologia e imunologia"}, {"en":"Autoimmune Dysregulation","zh":"自身免疫失调","ru":"Аутоиммунная дисрегуляция","ar":"خلل تنظيم المناعة الذاتية","es":"Deregulación autoinmune","fr":"Dysrégulation auto-immune","pt":"Desregulação autoim

# 慢性疲劳综合征（CFS）治疗方案与费用明细（风湿免疫科）

一、非手术/保守治疗方案

适用人群：确诊CFS（符合CDC或ICC标准）、无严重器质性病变、病程＜5年者。

• •基础评估费（血常规、ESR、CRP、甲状腺功能、维生素D/B12、EBV/HHV-6抗体、自身抗体谱）：860–1,250元
• •药物治疗（个体化）：

　• 对症用药（小剂量米氮平/加巴喷丁）：1,800–2,800元/年

• •认知行为疗法（CBT）+分级运动康复（GET）（）：4,200–6,800元

二、理 经颅磁刺激（rTMS，需医保备案）：320–450元/次 × 20次 = 6,400–9,000元

• •中医辨证调理（针灸+中药颗粒剂）：2,800–4,500元/疗程（3个月）

三、手术/介入/根治性方案

慢性疲劳综合征为功能性神经免疫障碍，无手术指征，风湿免疫科不开展任何外科、微创或介入治疗。所有”“神经调控植入”等方案均不符合诊疗规范，不在医保及公立三甲医院目录内。

四、复杂/耐药/并发症方案

合并自身免疫病（如干燥综合征、早期SSc）者：加用羟氯喹+小剂量糖皮质激素，年均总费用7,500–12,000元（含随访、肌电图、唾专项检查）。

五、方案快速选择指南

• •预算有限（≤1万元/年）：优选基础评估+CBT/GET+中医药调理；
• •中度症状伴免疫异常：增加低剂量纳曲酮+定期风湿免疫专科随访；
• •合并明确自身免疫病：启动规范化免疫干预，纳入慢病管理。